468 related articles for article (PubMed ID: 12754678)
21. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
[TBL] [Abstract][Full Text] [Related]
22. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.
McClintock SM; Husain MM; Greer TL; Cullum CM
Neuropsychology; 2010 Jan; 24(1):9-34. PubMed ID: 20063944
[TBL] [Abstract][Full Text] [Related]
23. Memory functioning in Lyme borreliosis.
Ravdin LD; Hilton E; Primeau M; Clements C; Barr WB
J Clin Psychiatry; 1996 Jul; 57(7):282-6. PubMed ID: 8666568
[TBL] [Abstract][Full Text] [Related]
24. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis.
Carter SL; Rourke SB; Murji S; Shore D; Rourke BP
Neuropsychology; 2003 Jul; 17(3):410-9. PubMed ID: 12959507
[TBL] [Abstract][Full Text] [Related]
25. Spiritual striving, acceptance coping, and depressive symptoms among adults living with HIV/AIDS.
PĂ©rez JE; Chartier M; Koopman C; Vosvick M; Gore-Felton C; Spiegel D
J Health Psychol; 2009 Jan; 14(1):88-97. PubMed ID: 19129341
[TBL] [Abstract][Full Text] [Related]
26. Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil.
Kamat R; Morgan E; Marcotte TD; Badiee J; Maich I; Cherner M; de Almeida S; de Pereira AP; Ribeiro CE; Barbosa F; Atkinson JH; Ellis R;
J Affect Disord; 2013 Sep; 150(3):1069-75. PubMed ID: 23245465
[TBL] [Abstract][Full Text] [Related]
27. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
[TBL] [Abstract][Full Text] [Related]
28. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
29. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study.
Olley BO; Seedat S; Stein DJ
J Psychosom Res; 2006 Oct; 61(4):479-84. PubMed ID: 17011355
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological functioning as a predictor of employment activity in a longitudinal study of HIV-infected adults contemplating workforce reentry.
Chernoff RA; Martin DJ; Schrock DA; Huy MP
J Int Neuropsychol Soc; 2010 Jan; 16(1):38-48. PubMed ID: 19765357
[TBL] [Abstract][Full Text] [Related]
31. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.
Rabkin JG; Ferrando SJ; van Gorp W; Rieppi R; McElhiney M; Sewell M
J Neuropsychiatry Clin Neurosci; 2000; 12(4):451-7. PubMed ID: 11083161
[TBL] [Abstract][Full Text] [Related]
32. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals.
Moore LH; van Gorp WG; Hinkin CH; Stern MJ; Swales T; Satz P
J Neuropsychiatry Clin Neurosci; 1997; 9(1):37-44. PubMed ID: 9017527
[TBL] [Abstract][Full Text] [Related]
33. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
[TBL] [Abstract][Full Text] [Related]
34. Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.
Baldewicz TT; Leserman J; Silva SG; Petitto JM; Golden RN; Perkins DO; Barroso J; Evans DL
AIDS Behav; 2004 Sep; 8(3):345-55. PubMed ID: 15475681
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).
Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR
J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503
[TBL] [Abstract][Full Text] [Related]
36. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results.
Moritz S; Ferahli S; Naber D
J Int Neuropsychol Soc; 2004 Jul; 10(4):623-33. PubMed ID: 15327740
[TBL] [Abstract][Full Text] [Related]
37. Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: relationship to premorbid abilities and symptom improvement.
Bayless JD; McCormick LM; Brumm MC; Espe-Pfeifer PB; Long JJ; Lewis JL
J ECT; 2010 Mar; 26(1):47-52. PubMed ID: 19710624
[TBL] [Abstract][Full Text] [Related]
38. The ecological validity of neuropsychological assessment and the role of depressive symptoms in moderate to severe traumatic brain injury.
Chaytor N; Temkin N; Machamer J; Dikmen S
J Int Neuropsychol Soc; 2007 May; 13(3):377-85. PubMed ID: 17445285
[TBL] [Abstract][Full Text] [Related]
39. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection.
Janssen RS; Saykin AJ; Cannon L; Campbell J; Pinsky PF; Hessol NA; O'Malley PM; Lifson AR; Doll LS; Rutherford GW
Ann Neurol; 1989 Nov; 26(5):592-600. PubMed ID: 2817835
[TBL] [Abstract][Full Text] [Related]
40. Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds.
Kalichman SC; Sikkema KJ; Somlai A
J Pers Assess; 1995 Feb; 64(1):86-100. PubMed ID: 7877094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]